Effect of PI3K/AKT Pathway on Cisplatin Resistance in Non-small Cell Lung Cancer
Accumulating evidences indicate that aberrant activation of PI3K/AKT pathway in non-small cell lung cancer plays a vital role in tumor cell proliferation,apoptosis, and survival including drug resistance. Cisplatin as first-line chemotherapy are in widespread clinical use in patients with non-small...
Enregistré dans:
| Auteurs principaux: | , , |
|---|---|
| Format: | Artigo |
| Langue: | Chinês |
| Publié: |
Chinese Anti-Cancer Association; Chinese Antituberculosis Association
2014-08-01
|
| Collection: | Chinese Journal of Lung Cancer |
| Sujets: | |
| Accès en ligne: | http://dx.doi.org/10.3779/j.issn.1009-3419.2014.08.09 |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|